Sandip I. Patel's most recent trade in Akari Therapeutics Plc - ADR was a trade of 225,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 20, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Akari Therapeutics Plc - ADR | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
Akari Therapeutics Plc - ADR | Sandip I. Patel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
Monterey Innovation Acquis... | Sandip I. Patel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.01 per share. | 09 Mar 2023 | 570,000 | 1,342,500 | - | 0.0 | 3,420 | Common Stock |
Monterey Innovation Acquis... | Sandip I. Patel | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Mar 2023 | 75,000 | 1,417,500 | - | - | Common Stock |